!IONSOURCE for Biotechnologies - Medical & pharmaceutical research industry.>
We are able to identify poorly expressed proteins
We identify proteins that are difficult to detect
Recombinant proteins and post-translational modifications
Separation of different molecules in biofluids
Acquisition of characteristic molecular signals
Acquisition of information in biological samples
Biomarker analysis in prediction of cancer
Strategies for targeted molecular therapies
Definition of therapeutic response assays
Trust our SANIST proprietary technology. ISB SRL’s proprietary platform is the result of over 10 years of experience in the field of mass spectrometry.
ISB SRL implements the Blockchain technology for quality control. Each file and activity is irreversibly and permanently tracked and can be traced back using a specific search engine.
Laboratories are located within the OpenZone technological hub, where Italian excellence in the biotechnology and bioinformatics sector is incubated. Our laboratories and offices are available to customers at the following times:
|Monday||-||9:00 AM - 6:00 PM|
|Tuesday||-||9:00 AM - 6:00 PM|
|Wednesday||-||9:00 AM - 6:00 PM|
|Thursday||-||9:00 AM - 6:00 PM|
|Friday||-||9:00 AM - 6:00 PM|
ISB was established as a spin-off of Università degli Studi di Milano in 2006, and comprises researchers with fields of study covering a wide range of different scientific sectors and disciplines; this multidisciplinarity enables ISB to tackle many types of problems, both in the biomedical-scientific area and in the pharmaceutical, food and environmental area.
We identify proteins and characterize their structure in terms of modifications and biochemical activity.
We study the metabolic molecular profiles in biological matrices (e.g. urine and plasma) and we associate them with the prevention and onset of degenerative diseases of the organism.
Metabolomic and proteomic analyses are applied to the study of food, in order to evaluate its beneficial or harmful effects on the human organism.
ISB is able to identify small-dimension molecules and characterize their structure via mass spectrometry and dedicated bioinformatic platforms.
In the field of mass spectrometry we develop analytical methods or improve existing ones in the biomedical-scientific, food and environmental fields.
Technique applied to the quali-quantitative analysis of molecules extracted from different matrices.
We use the SACI source for high-precision advanced proteomic analyses in both quality and quantity terms.
The USIS ionization source is applied in the analysis of complex molecular profiles, particularly in the metabolomic field. It expands and maximizes the range of molecules that can be analyzed.
10 years of experience in the field of mass spectrometry and 2 patents: innovative SANIST platform for performing targeted and non-targeted molecular analyses.
Blockchain technology for quality control. Each file and activity can be traced using a multi-distributed unchangeable database in the Blockchain.
The SANIST technology is used to obtain the detailed molecular composition of food, highlighting its nutritional properties.
The global market offers an ever-increasing number of products and supplements of uncertain origin and identity. For this reason, our laboratory specializes in the control of commercial products: food supplements, etc.
AMCO blood drop: oxidative stress evaluation by means of blood drops deposited on the absorbent part of a commercial patch.
Aimed at identifying any imbalances in gut bacteria and how they are related to disease.
Examination of urinary thiodiglycolic acid can be useful for evaluating oxidative stress and consequently the probability of onset of degenerative diseases: cancer, sclerosis, etc.
Biomarkers can be used to diagnose or monitor the activity of a disease, to guide targeted molecular therapies or for therapeutic response assays.
Analysis of the metabolic molecular profile of the breath represents the new frontier in early diagnosis and prevention of disease.
Medical research is moving towards selective accurate approaches to prevent and diagnose diseases.
The SANIST technology helps to prevent degenerative diseases by efficient monitoring of an individual’s biochemical activities.
We apply the SANIST technology to verify the composition and alteration of pharmaceutical products.
This is where we can help you: We carefully check the composition of the product individually identifying each component and carefully analyzing each of them at molecular level. This provides important information in order to guarantee the quality of the food supplement.
Our intervention will enable you to:
Offer your products for sale in record time speeding up the journey from molecule to market, thanks to a series of procedures designed to ensure compliance with ministerial requirements.
Rapidly obtain the appropriate certifications to make your products market compliant and obtain all the necessary sale documents.
We carefully check the composition of the product individually, identifying each component and carefully analyzing each of them at protein and molecular level.
Access important information and consulting services to produce high-end superior quality food products.
Our training services for training your specialist personnel to operate in complete safety and total autonomy with guaranteed results..
Analysis and certification in outsourcing for all products entering the sales chain.Further details
Our patented SANIST technology applied to pharmaceutical products enables us to:
Verify the cause of any product alterations(e.g. color variation) by identifying the molecular changes that have caused the non-conformity..
Verify the various molecular interactions (Interactome), for example study of the drug-protein interaction in vitro.
We create research and development projects to identify new opportunities for improving your products, and we discuss and customize the research based on your requirements.
In order to understand how we can really help companies to penetrate the market, we first need to know what our clients say about us:
The ISB team’s enthusiasm, cohesion and willingness to collaborate are an ongoing example for me.
This group provides high-quality research in the early diagnosis of cancer.
The ability to go straight to the target and solved our problems with mass spectrometry experiments.
Identify Biomarkers used to prevent, diagnose or monitor the activity of a disease.
Identify unknown molecules based on their molecular weight and fragmentation spectrum.
Identify unknown matrices (e.g. plant extracts).
Construct new diagnostic models based on the quantity of specific molecular biomarkers.
Research models activated
IS Biolab works not only with commercial companies, it also has various collaborations and synergies with bodies and facilities, including public organizations, that benefit from its many years of specialization in the sector.
A proprietary technological platform and a patented method consolidated over time, designed to provide Biotechnology and Bioengineering services for firms operating in Clinical Research or areas relating to the Pharmaceutical, Food, Nutraceutics and Cosmetics industries. What sector do you operate in?
Foodomics services to guarantee food traceability, and for toxicological control of food products.
Verification of composition or alteration of pharmaceutical products, research and development services and improvement of product functionality.
Development and improvement of nutritional value of food supplements, search for fakes and protection against attempts at reverse engineering.